<DOC>
	<DOCNO>NCT02697045</DOCNO>
	<brief_summary>Nautralsitic , Open-label , Single Arm , Uncontrolled Study Evaluating Effects Long Acting Injectable ( LAI ) Phychosocial Functioning Congitive Functioning Patient Reported Acceptability Treatment 'Reported Acceptability Treatment ' Regarding Quality Life Subjective Well-being Under Neuroleptic Medication Schizophrenia Patients</brief_summary>
	<brief_title>Effects Aripiprazole ( LAI ) Phychosocial/Cognitive Functioning , pt Reported AcceptabilityofTreatment Sch</brief_title>
	<detailed_description>Primary Objective - To evaluate efficacy aripiprazole long act injectable form Turkish patient schizophrenia psychosocial functioning , quality life patient report acceptability treatment . Secondary Objective ( ) - To evaluate cognitive functioning patient - To evaluate positive negative symptom Aripiprazole Long Acting Injectable ( LAI ) , - To evaluate adherence Aripiprazole Long Acting Injectable ( LAI ) treatment , - To evaluate tolerability Aripiprazole Long Acting Injectable ( LAI ) .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Participants 1845 year age fulfil DSMIVTR diagnostic criterion schizophrenia , Disease history ≤ 3 year ( ≤ 3 year emergence first psychotic symptom ) , A history symptom exacerbation relapse receive antipsychotic therefore require maintenance antipsychotic treatment , Informed write consent , Not antipsychotic treatment least 3 month require switch treatment reason ( lack efficacy/ inadequate response current antipsychotic ( ) , intolerance , nonadherence ) , potential benefit extend treatment LAI formulation , investigator 's opinion . Lack efficacy define subject baseline total PANSS score ≥70 ≥2 item score ≥4 Positive Negative Symptom Subscale Lack tolerability define presence clinically relevant side effect previous antipsychotic medication . Being literate order able answer self report scale . DSMIVTR diagnosis schizophrenia experience acute depressive symptom past 30 day require ADT depend clinical decision investigator . Antipsychotic resistant refractory schizophrenia A history failure clozapine treatment response clozapine treatment . Significant risk violent behavior risk selfharm Currently meet DSMIVTR criterion alcohol substance dependence Any clinically significant medical neurological disorder Any medically significant abnormal laboratory test ECG result screen Pregnant , lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Functionality</keyword>
	<keyword>Long Acting Injectable</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>Naturalistic</keyword>
	<keyword>Open-label</keyword>
	<keyword>Single Arm</keyword>
	<keyword>Uncontrolled Study</keyword>
</DOC>